(E)-1-[7-[2-(4-acetylphenyl)acetyl]-1,3-dimethyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]-1-[2-ethyl-7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-3-methyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one;(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-2,3-dimethyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one
C85H79Cl3FN21O9 — CID 157050717
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-1-[7-[2-(4-acetylphenyl)acetyl]-1,3-dimethyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]-1-[2-ethyl-7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-3-methyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one;(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-2,3-dimethyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one
(E)-1-[7-[2-(4-acetylphenyl)acetyl]-1,3-dimethyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]-1-[2-ethyl-7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-3-methyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one;(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-2,3-dimethyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one (PubChem CID 157050717) has the molecular formula C85H79Cl3FN21O9 and a molecular weight of 1664.06 g/mol. Its IUPAC name is (E)-1-[7-[2-(4-acetylphenyl)acetyl]-1,3-dimethyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]-1-[2-ethyl-7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-3-methyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one;(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-2,3-dimethyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one.
Molecular Properties
| Compound Name | (E)-1-[7-[2-(4-acetylphenyl)acetyl]-1,3-dimethyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]-1-[2-ethyl-7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-3-methyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one;(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-2,3-dimethyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one |
|---|---|
| PubChem CID | 157050717 |
| Molecular Formula | C85H79Cl3FN21O9 |
| Molecular Weight | 1664.06 g/mol |
| Exact Mass | 1661.54 |
| IUPAC Name | (E)-1-[7-[2-(4-acetylphenyl)acetyl]-1,3-dimethyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-en-1-one;(E)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]-1-[2-ethyl-7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-3-methyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one;(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-[7-[2-[4-(1-hydroxyethenyl)phenyl]acetyl]-2,3-dimethyl-5,7-dihydro-4H-pyrazolo[3,4-c]pyridin-6-yl]prop-2-en-1-one |
| SMILES | C=C(O)c1ccc(CC(=O)C2c3nn(C)c(C)c3CCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1.C=C(O)c1ccc(CC(=O)C2c3nn(CC)c(C)c3CCN2C(=O)/C=C/c2c(-n3cnnn3)ccc(Cl)c2F)cc1.CC(=O)c1ccc(CC(=O)C2c3c(c(C)nn3C)CCN2C(=O)/C=C/c2cc(Cl)ccc2-n2cnnn2)cc1 |
| InChI | InChI=1S/C29H27ClFN7O3.2C28H26ClN7O3/c1-4-37-17(2)21-13-14-36(29(28(21)33-37)25(40)15-19-5-7-20(8-6-19)18(3)39)26(41)12-9-22-24(38-16-32-34-35-38)11-10-23(30)27(22)31;1-17-23-12-13-35(26(39)11-8-21-15-22(29)9-10-24(21)36-16-30-32-33-36)28(27(23)31-34(17)3)25(38)14-19-4-6-20(7-5-19)18(2)37;1-17-23-12-13-35(26(39)11-8-21-15-22(29)9-10-24(21)36-16-30-32-33-36)28(27(23)34(3)31-17)25(38)14-19-4-6-20(7-5-19)18(2)37/h5-12,16,29,39H,3-4,13-15H2,1-2H3;4-11,15-16,28,37H,2,12-14H2,1,3H3;4-11,15-16,28H,12-14H2,1-3H3/b12-9+;2*11-8+ |
| InChIKey | AAECDINWLPBDPK-OFMODOKRSA-N |
| XLogP | 11.81 |
| TPSA | 353.93 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 119 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1664.06 |
| LogP ≤ 5 | 11.81 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 27 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157050717 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.